4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-060115
Chief Scientific Officer sold 11,685 shares at an average $32.95 ($385,018)
- Chief Scientific Officer acquired 11,685 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBINS HARLAN S · Chief Scientific Officer
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-06 | Exercise or conversion : show line 1 in the form | +3,895 | $6.32 | $24,616 | 73,255 | D |
| 2021-10-06 | Sale : show line 2 in the form | −3,895 | $32.27 | $125,692 | 69,360 | D |
| 2021-10-07 | Exercise or conversion : show line 3 in the form | +3,895 | $6.32 | $24,616 | 73,255 | D |
| 2021-10-07 | Sale : show line 4 in the form | −200 | $32.50 | $6,500 | 73,055 | D |
| 2021-10-07 | Sale : show line 5 in the form | −3,695 | $33.68 | $124,448 | 69,360 | D |
| 2021-10-08 | Exercise or conversion : show line 6 in the form | +3,895 | $6.32 | $24,616 | 73,255 | D |
| 2021-10-08 | Sale : show line 7 in the form | −3,895 | $32.96 | $128,379 | 69,360 | D |
| Open-market sales · 11,685 sh · avg $32.95 · $385,018 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-06 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −3,895 | 77,900 | D |
| 2021-10-07 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −3,895 | 74,005 | D |
| 2021-10-08 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −3,895 | 70,110 | D |
Loading xslF345X03/doc4.xml…